|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.445 USD | +0.73% |
|
-11.44% | +13.32% |
| Apr. 04 | UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating | MT |
| Apr. 01 | Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating | MT |
▪
▪
▪
▪
▪
▪
▪
Attachments
Disclaimer
Kodiak Sciences Inc. published this content on 09 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 22:00:03 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.32% | 179M | |
| -0.51% | 103B | |
| +3.54% | 96.73B | |
| +1.66% | 21.31B | |
| -16.26% | 21.21B | |
| -6.82% | 18.79B | |
| -41.41% | 16.37B | |
| -23.31% | 13.68B | |
| +6.21% | 13.44B | |
| +22.71% | 10.98B |
KODIAK SCIENCES INC. 
